RI biotech Bolden Therapeutics raises $1.5M to advance Alzheimer's work

Bolden, a Brown University spinoff, is working on neurogenesis — the formation of new brain cells in adults.

Source: bizjournals.com Health Care:Biotechnology headlines - January 22, 2024 Category: Biotechnology Authors: Mary Serreze Source Type: news